Yvonne Hui Sells 1,371 Shares of Phreesia (NYSE:PHR) Stock

Phreesia, Inc. (NYSE:PHR – Get Free Report) insider Yvonne Hui sold 1,371 shares of the business’s stock in a transaction dated Monday, July 6th. The stock was sold at an average price of $10.84, for a total value of $14,861.64. Following the transaction, the insider directly owned 23,908 shares of the company’s stock, valued at approximately $259,162.72. The trade was a 5.42% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Yvonne Hui also recently made the following trade(s):

Get Phreesia alerts:

• On Friday, April 17th, Yvonne Hui sold 1,327 shares of Phreesia stock. The shares were sold at an average price of $9.28, for a total transaction of $12,314.56.
• On Thursday, April 16th, Yvonne Hui sold 10,063 shares of Phreesia stock. The shares were sold at an average price of $9.08, for a total transaction of $91,372.04.

Phreesia Price Performance

PHR stock opened at $10.65 on Thursday. The company has a 50 day simple moving average of $9.58 and a 200 day simple moving average of $11.63. The stock has a market cap of $658.59 million, a price-to-earnings ratio of 71.03 and a beta of 0.87. Phreesia, Inc. has a 1 year low of $7.77 and a 1 year high of $32.76. The company has a debt-to-equity ratio of 0.41, a current ratio of 1.76 and a quick ratio of 1.76.

Phreesia (NYSE:PHR – Get Free Report) last issued its quarterly earnings data on Wednesday, May 27th. The company reported $0.05 EPS for the quarter, beating the consensus estimate of $0.02 by $0.03. The business had revenue of $130.94 million during the quarter, compared to the consensus estimate of $130.08 million. Phreesia had a net margin of 1.85% and a return on equity of 5.13%. The firm’s revenue was up 12.9% compared to the same quarter last year. During the same quarter in the prior year, the firm earned ($0.07) EPS. Research analysts anticipate that Phreesia, Inc. will post 0.39 EPS for the current fiscal year.

Wall Street Analyst Weigh In

A number of equities research analysts recently weighed in on PHR shares. Robert W. Baird restated a “neutral” rating and set a $10.00 price objective (down from $25.00) on shares of Phreesia in a research report on Tuesday, March 31st. Stephens dropped their target price on Phreesia from $32.00 to $20.00 and set an “overweight” rating for the company in a research report on Tuesday, March 31st. Needham & Company LLC reduced their price target on Phreesia from $35.00 to $14.00 and set a “buy” rating on the stock in a report on Tuesday, March 31st. Truist Financial raised their price objective on shares of Phreesia from $11.00 to $12.00 and gave the company a “hold” rating in a report on Thursday, May 28th. Finally, Canaccord Genuity Group cut their target price on shares of Phreesia from $22.00 to $16.00 and set a “buy” rating on the stock in a research report on Thursday, May 28th. Nine research analysts have rated the stock with a Buy rating, nine have given a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Hold” and an average price target of $16.65.

Get Our Latest Stock Analysis on Phreesia

Hedge Funds Weigh In On Phreesia

Hedge funds and other institutional investors have recently bought and sold shares of the company. NewEdge Advisors LLC lifted its stake in shares of Phreesia by 2,395,000.0% in the 1st quarter. NewEdge Advisors LLC now owns 23,951 shares of the company’s stock valued at $201,000 after purchasing an additional 23,950 shares during the period. Essential Partners LLC increased its stake in shares of Phreesia by 2,016.6% in the 1st quarter. Essential Partners LLC now owns 9,313 shares of the company’s stock valued at $78,000 after acquiring an additional 8,873 shares in the last quarter. Bank of America Corp DE increased its stake in shares of Phreesia by 142.6% in the 1st quarter. Bank of America Corp DE now owns 1,001,057 shares of the company’s stock valued at $8,389,000 after acquiring an additional 588,444 shares in the last quarter. Amundi acquired a new position in shares of Phreesia during the 1st quarter valued at $401,000. Finally, EverSource Wealth Advisors LLC lifted its position in shares of Phreesia by 1,119.8% during the 1st quarter. EverSource Wealth Advisors LLC now owns 3,269 shares of the company’s stock valued at $27,000 after acquiring an additional 3,001 shares during the period. Institutional investors and hedge funds own 92.10% of the company’s stock.

Phreesia News Roundup

Here are the key news stories impacting Phreesia this week:

• Negative Sentiment: Several firms, including Glancy Prongay Wolke & Rotter, Faruqi & Faruqi, Rosen, Pomerantz, Holzer & Holzer, and others, renewed reminders about the Phreesia securities class action and the July 13 lead-plaintiff deadline, keeping legal overhang front and center for investors. Article Title
• Negative Sentiment: The lawsuit alleges Phreesia and certain officers made false or misleading statements about growth prospects, especially around the Network Solutions business and fiscal 2027 revenue expectations, which could affect confidence in management guidance. Article Title
• Negative Sentiment: Insider selling added a mild bearish signal: Phreesia insider Yvonne Hui sold 1,371 shares in a pre-arranged Rule 10b5-1 transaction, which investors may view cautiously while litigation uncertainty persists. Article Title

Phreesia Company Profile

(Get Free Report)

Phreesia, Inc (NYSE: PHR) is a provider of patient intake management solutions designed to streamline front-office workflows for healthcare organizations. The company’s cloud-based platform digitizes patient registration, appointment scheduling, insurance verification, consent documentation and payment collection through touchscreen kiosks, tablets and mobile devices. By replacing paper forms and manual processes, Phreesia enhances data accuracy, reduces administrative burden and improves the patient experience.

Founded in 2000 by Chaim Indig and headquartered in Burlington, Massachusetts, Phreesia offers a modular software suite that integrates with electronic medical record (EMR) and practice management systems.

Featured Articles

• Five stocks we like better than Phreesia
• A Market Panic Just Discounted the AI Highway’s Tollbooth
• Why Exxon Could Be the Market’s Next Big Comeback Stock
• The Market Just Got Shaken—These 3 ETFs May Come Out Stronger
• Meta Platforms’ Cloud Push: Growth Opportunity Versus AI Concerns

Receive News & Ratings for Phreesia Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phreesia and related companies with MarketBeat.com's FREE daily email newsletter.